Skip to main content
SpringerLink
Log in

Cardiovascular Complications in Acromegaly: Methods of Assessment

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

Cardiac involvement is common in acromegaly. Evidence for cardiac hypertrophy, dilation and diastolic filling abnormalities has been widely reported in literature. Generally, ventricular hypertrophy is revealed by echocardiography but early data referred increased cardiac size by standard X-ray. Besides, echocardiography investigates cardiac function and value disease. There are new technologic advances in ultrasonic imaging. Pulsed Tissue Doppler is a new non-invasive ultrasound tool which extends Doppler applications beyond the analysis of intra-cardiac flow velocities until the quantitative assessment of the regional myocardial left ventricular wall motion, measuring directly velocities and time intervals of myocardium. The radionuclide techniques permit to study better the cardiac performance. In fact, diastolic as well as systolic function can be assessed at rest and at peak exercise by equilibrium radionuclide angiography. This method has a main advantage of providing direct evaluation of ventricular function, being operator independent. Coronary artery disease has been poorly studied mainly because of the necessity to perform invasive procedures. Only a few cases have been reported with heart failure study by coronarography and having alterations of perfusion which ameliorated after somatostatin analog treatment. More recently, a few data have been presented using perfusional scintigraphy in acromegaly, even if coronary artery disease does not seem very frequent in acromegaly. Doppler analysis of carotid arteries can be also performed to investigate atherosclerosis: however, patients with active acromegaly have endothelial dysfunction more than clear-cut atherosclerotic plaques. In conclusion, careful assessments of cardiac function, morphology and activity need in patients with acromegaly.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Delafontaine P. Insulin-like growth factor I and its binding proteins in the cardiovascular system. Cardiovasc Res 1995;30:825.

    Google Scholar 

  2. Isgaard J, Nilsson A, Vickman K, Isaksson OGP. Growth hormone regulates the level of insulin-like growth factor-I mRNA in rats skeletal muscle. J Endocrinol 1989;120:107.

    Google Scholar 

  3. Toyozaki T, Hiroe M, Hasumi M, Horie T, Hosoda S, Tsushima T, Sekiguchi M. Insulin like growth factor I receptors in human cardiac myocytes and their relation to myocardial hypertrophy. Jpn Circulation J 1993;57:1120.

    Google Scholar 

  4. Wright AD, Hill DM, Lowy C, Fraser TR. Mortality in acromegaly. Q J Med 1970;39:1.

    Google Scholar 

  5. McGuffin WL Jr, Sherman BM, Roth J, Gorden P, Kahn CR, Roberts WC, Frommer PL. Acromegaly and cardiovascular disorders: A prospective study. Ann Intern Med 1974;81:11.

    Google Scholar 

  6. Colao A, Marzullo P, Di Somma C, Lombardi G. Growth hormone and heart. Clin Endocrinol 2001;54:137.

    Google Scholar 

  7. Fazio S, Cittadini A, Sabatini D, Merola B, Colao A, Biondi B, Lombardi G, Saccà L. Evidence for biventricular involvement in acromegaly: A Doppler echocardiographic study. Eur Heart J 1993;14:26.

    Google Scholar 

  8. Hunter JJ, Chien KR. Signalling pathways for cardiac hypertrophy and failure. N Engl J Med 1999;341:1276.

    Google Scholar 

  9. Lombardi G, Colao A, Marzullo P, Ferone D, Longobardi S, Esposito V, Merola B. Is growth hormone bad for your heart? Cardiovascular impact of GH deficiency and of acromegaly. J Endocrinol 1997;155:S33.

    Google Scholar 

  10. Colao A, Baldelli R, Marzullo P, Ferretti E, Ferone D, Gargiulo P, Petretta M, Tamburrano G, Lombardi G, Liuzzi A. Systemic hypertension and impaired glucose tolerance are independently correlated to the severity of the acromegalic cardiomyopathy. J Clin Endocrinol Metab 2000;85: 193.

    Google Scholar 

  11. Marzullo P, Cuocolo A, Ferone D, Pivonello R, Salvatore M, Lombardi G, Colao A. Cardiac effect of thyrotoxicosis in acromegaly. J Clin Endocrinol Metab 2000;85:1426.

    Google Scholar 

  12. Courville C, Mason VR. The heart in acromegaly. Arch Int Med 1938;61:704.

    Google Scholar 

  13. Hejtmancik MR, Bradfield JY, Herrmann GR. Acromegaly and the heart: A clinical and pathologic study. Ann Intern Med 1951;34:1445.

    Google Scholar 

  14. Lie JT, Grossman SJ. Pathology of the heart in acromegaly: Anatomic findings in 27 autopsied patients. Am Heart J 1980;100:41.

    Google Scholar 

  15. Hayward RP, Emanuel RW, Nabarro JDN. Acromegalic heart disease: Influence of treatment of the acromegaly on the heart. Q J Med 1987;62:41.

    Google Scholar 

  16. Levy D, Labib SB, Anderson KM, Christiansen JC, Kannel WB, Castelli WP. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 1990;81:815.

    Google Scholar 

  17. Luboshitzki R, Hammerman H, Barzilai D, Markiewicz W. The heart in acromegaly: Correlation of echocardiographic and clinical findings. Isr J Med Sci 1980;16:378.

    Google Scholar 

  18. Levy D, Savage DD, Garrison RJ, Anderson KM, Kannel WB, Castelli WP. Echocardiographic criteria for left ventricular hypertrophy: The Framingham Heart Study. Am J Cardiol 1987;59:956.

    Google Scholar 

  19. Devereux RB, Reicheck N. Echocardiographic determination of left ventricular mass: Anatomic validation of the method. Circulation 1977;55:613.

    Google Scholar 

  20. American Society of Echocardiography Committee on standards, subcommittee on quntification of two-dimensional echocardiograms: Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358.

    Google Scholar 

  21. de Simone G, Daniels SR, Devereux RB, Meyer RA, Roman MJ, de Divitiis O, Laragh J. Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight. J Am Coll Cardiol 1992;20(5):1251.

    Google Scholar 

  22. Devereux RB. Detection of left ventricular hypertrophy by M mode echocardiography. Anatomic validation, standardization and comparison to other methods. Hypertension 1987;9:19.

    Google Scholar 

  23. Minniti G, Jaffrain-Rea ML, Moroni C, Baldelli R, Ferretti E, Cassone R, Gulino A, Tamburrano G. Echocardiographic evidence for a direct effect ofGH/IGF-I hypersecretion on cardiac mass and function in young acromegalics. Clin Endocrinol 1998;49:101.

    Google Scholar 

  24. López-Velasco R, Escobar-Morreale HF, Vega B, Villa E, Sancho JM, Moya-Mur JL, Garcia-Robles R. Cardiac involvement in acromegaly: Specific myocardiopathy or consequence of systemic hypertension. J Clin Endocrinol Metab 1997;82: 1047.

    Google Scholar 

  25. Saccà L, Cittadini A, Fazio S. Growth hormone and the heart. Endocr Rev 1994;15:555.

    Google Scholar 

  26. Zlatareva N, Andreeva M, Angelova I. Echocardiographic evaluation of left ventricular function in acromegaly patients. J Bulgarian Soc Endocrinol 2000.

  27. Cable DG, Dearani JA, O'Brien T, Orszulak TA, Puga FJ, Schaff HV. Surgical treatment of valvular heart disease in patients with acromegaly. J Heart Valve Dis 2000;9:828.

    Google Scholar 

  28. Ohtsuka G, Aomi S, Koyanagi H, Tsukui H, Tomizawa Y, Hashimoto A, Sakomura Y. Heart valve operation in acromegaly. Ann Thor Surg 1997;64:390.

    Google Scholar 

  29. Bonow RO, Bacharach SL, Green MV, Kent KM, Rosing DR, Lipson LC, Leon MB, Epstein SE. Impaired left ventricular diastolic filling in patients with coronary artery disease: Assessment with radionuclide angiography. Circulation 1981;64:315.

    Google Scholar 

  30. Bonow RO, Vitale DF, Bacharach SL, Frederick TM, Kent KM, Green MV. Asynchronous left ventricular regional function and impaired global diastolic filling in patients with coronary artery disease: Reversal after coronary angioplasty. Circulation 1985;71:297.

    Google Scholar 

  31. Bonow RO, Vitale DF, Bacharach SL, Maron BJ, Green MV. Effects of aging on asynchronous left ventricular regional function and global ventricular filling in normal human subjects. J Am Coll Cardiol 1988;11:50.

    Google Scholar 

  32. Cuocolo A, Nicolai E, Fazio S, Pace L, Maurea S, Cittadini A, Saccà L, Salvatore M. Impaired left ventricular diastolic filling in patients with acromegaly: Assessment with radionuclide angiography. J Nucl Med 1995;36:196.

    Google Scholar 

  33. Fazio S, Cittadini A, Cuocolo A, Merola B, Sabatini D, Colao A, Biondi B, Lombardi G, Saccà L. Impaired cardiac performance is a distinct feature of uncomplicated acromegaly. J Clin Endocrinol Metab 1994;79:441.

    Google Scholar 

  34. Colao A, Cuocolo A, Marzullo P, Nicolai E, Ferone D, Della Morte A, Salvatore M, Lombardi G. Impact of patient's age and disease duration on cardiace performance in acromegaly: A radionuclide angiography study. J Clin Endocrinol Metab 1999;84:1518.

    Google Scholar 

  35. Harrison BD, Millhouse KA, Harrington M, Nabarro JD. Lung function in acromegaly. Q J Med 1978;47:517.

    Google Scholar 

  36. Surawicz B, Mangiardi ML. Electrocardiogram in endocrine and metabolic disorders. Cardiovasc Clin 1977;8:243.

    Google Scholar 

  37. Colao A. Are patients with acromegaly at risk for dysrhythmias? Clin Endocrinol 2001;55:305.

    Google Scholar 

  38. Kahaly G, Olshausen KV, Mohr-Kahaly S, Erbel R, Boor S, Beyer J, Meyer J. Arrhythmia profile in acromegaly. Eur Heart J 1992;3:51.

    Google Scholar 

  39. Rodrigues EA, Caruana MP, Lahiri A, Nabarro JD, Jacobs HS, Raftery EB. Subclinical cardiac dysfunction in acromegaly evidence for a specific disease of heart muscle. Br Heart J 1989;62:185.

    Google Scholar 

  40. Lombardi G, Colao A, Marzullo P, Biondi B, Palmieri E, Fazio S, the Multicenter Study Group on Lanreotide. Improvement of left ventricular hypertrophy and arrhytmias after lanreotideinduced growth hormone and insulin-like growth factor-I decrease in acromegaly: A prospective multicenter study. J Endocrinol Invest 2002; in press.

  41. Colao A, Spiezia S, Cerbone G, Pivonello R, Marzullo P, Ferone D, Di Somma C, Assanti AP, Lombardi G. Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly. Clin Endocrinol 2001;54:515.

    Google Scholar 

  42. Kahn AM, Siedel CL, Allen JC, O'Neil RG, Shelat H, Hong T. Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle. Hypertension 1993;22:735.

    Google Scholar 

  43. Sowers JR, Standley PR, Ram JL, Jacober S. Hyperinsulinemia, insulin resistance, and hyperglycemia: Contributing factors in the pathogenesis of hypertension and atherosclerosis. Am J Hypertension 1993;6:260S.

    Google Scholar 

  44. Wu HY, Yue CJ, Chyu KY, Hsuch WA, Chan TM. Endothelialdependent vascular effects of insulin and insulin-like growth factor I in the perfused rat mesenteric artery and aortic ring. Diabetes 1994;43:1027.

    Google Scholar 

  45. Colao A, Marzullo P, Lombardi G, Italian Multicenter Study Group on Lanreotide. Effects of a six-month treatment with lanreotide on cardiovascular risk factors and arterial intimamedia thickness in patients with acromegaly.Eur J Endocrinol 2002;146:303–309.

    Google Scholar 

  46. Drexler H, Zeiher A, Wollschlager H, Meindertz T, Just H, Bonzel T. Flowdependent artery dilation in humans. Circulation 1989;80:466–474.

    Google Scholar 

  47. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, Loyd JK, Deanfield JE. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992;340:1111.

    Google Scholar 

  48. Anderson TJ, Ulhata A, Gerhard MD, Meredith IT, Knab S, Delagrange D, Lieberman EH, Ganz P, Creager HA, Yeung AC. Close relation of endothelial function in the human coronary and peripheral circulation. J Am Coll Cardiol 1995;26: 1235.

    Google Scholar 

  49. Brevetti G, Martone VD, de Cristofaro T, Corrado S, Silvestro A, Di Donato AM, Bucur R, Scopacasa F. High levels of adhesion molecules are associated with impaired endotheliumdependent vasodilation in patients with peripheral arterial disease. Thromb Haemost 2001;85:63.

    Google Scholar 

  50. Celermajer DS, Sorensen KE, Bull C, Robinson J, Deanfield JE. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol 1994;24:1468.

    Google Scholar 

  51. Brevetti G, Marzullo P, Silvestro A, Pivonello R, Oliva G, Di Somma C, Lombardi G, Colao A. Early vascular alterations in acromegaly. J Clin Endocrinol Metab 2002;87:317.

    Google Scholar 

  52. Isaaz K, Thompson A, Ethevenot G, Cloez JL, Brembilla B, Pernot C. Doppler echocardiography measurement of low velocity motion of the left ventricular posterior wall. Am J Cardiol 1989;64:66.

    Google Scholar 

  53. McDicken WN, Sutherland GR, Gordon LN. Color Doppler velocity imaging of the myocardium. Ultrasound Med Biol 1992;18:651.

    Google Scholar 

  54. Sutherland GR, Steward MJ, Grounstroem KWE, Moran CM, Fleming A, Guell-Peris FJ, Riemersma RA, Fennen LN, Fox KA, McDicken WN. Color Doppler myocardial imaging: A new technique for the assessment of myocardial function. J AmSoc Echocardiogr 1994;7:441.

    Google Scholar 

  55. Mercuro G, Zoncu S, Colonna P, Cherchi P, Mariotti S, Pigliaru F, Petrini L, Iliceto S. Cardiac dysfunction in acromegaly: Evidence by pulsed wave tissue Doppler imaging. Eur J Endocrinol 2000;143:363.

    Google Scholar 

  56. Caiati C, Montaldo C, Zedda N, Bina A, Iliceto S. A new noninvasive method for coronary flow reserve assessment: Contrast enhanced transthoracic second harmonic echo Doppler. Circulation 1999;99:771.

    Google Scholar 

  57. Galderisi M, Cicala S, De Simone L, Caso P, Petrocelli A, Pietropaolo I, Celentano A, Mininni N, de Divitiis O. Coronary flow reserve and myocardial diastolic dysfunction in hypertensive patients with left ventricular hypertrophy. It Heart J 2001;2(9):677.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular and Clinical Endocrinology and Oncology, “Federico II”, University of Naples, Via Pansini 5, 80131, Naples, Italy

    Giovanni Vitale, Rosario Pivonello, Giovanni Lupoli, Gaetano Lombardi & Annamaria Colao

  2. Department of Clinical and Experimental Medicine, Chair of Emergency Medicine, “Federico II”, University of Naples, Via Pansini 5, 80131, Naples, Italy

    Maurizio Galderisi & Arcangelo D'Errico

  3. Department of Medicine I, “Federico II”, University of Naples, Via Pansini 5, 80131, Naples, Italy

    Letizia Spinelli

Authors
  1. Giovanni Vitale
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rosario Pivonello
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maurizio Galderisi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arcangelo D'Errico
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Letizia Spinelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Giovanni Lupoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Gaetano Lombardi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Annamaria Colao
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vitale, G., Pivonello, R., Galderisi, M. et al. Cardiovascular Complications in Acromegaly: Methods of Assessment. Pituitary 4, 251–257 (2001). https://doi.org/10.1023/A:1020750514954

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020750514954

Search

Navigation